Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for agriculture industry professionals · Friday, March 29, 2024 · 699,705,495 Articles · 3+ Million Readers

Market Trends Toward New Normal in PTC Therapeutics, AeroVironment, Autodesk, Coca-Cola Bottling Co. Consolidated, Akers Biosciences, and TEGNA — Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PTC Therapeutics, Inc. (NASDAQ:PTCT), AeroVironment, Inc. (NASDAQ:AVAV), Autodesk, Inc. (NASDAQ:ADSK), Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE), Akers Biosciences Inc (NASDAQ:AKER), and TEGNA Inc. (NYSE:TGNA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

PTCT DOWNLOAD: http://Fundamental-Markets.com/register/?so=PTCT
AVAV DOWNLOAD: http://Fundamental-Markets.com/register/?so=AVAV
ADSK DOWNLOAD: http://Fundamental-Markets.com/register/?so=ADSK
COKE DOWNLOAD: http://Fundamental-Markets.com/register/?so=COKE
AKER DOWNLOAD: http://Fundamental-Markets.com/register/?so=AKER
TGNA DOWNLOAD: http://Fundamental-Markets.com/register/?so=TGNA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine PTC Therapeutics, Inc. (NASDAQ:PTCT), AeroVironment, Inc. (NASDAQ:AVAV), Autodesk, Inc. (NASDAQ:ADSK), Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE), Akers Biosciences Inc (NASDAQ:AKER), and TEGNA Inc. (NYSE:TGNA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

PTC THERAPEUTICS, INC. (PTCT) REPORT OVERVIEW

PTC Therapeutics' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, PTC Therapeutics reported revenue of $68.74MM vs $47.96MM (up 43.33%) and analysts estimated basic earnings per share -$0.21 vs -$0.44. For the twelve months ended December 31st, 2017 vs December 31st, 2016, PTC Therapeutics reported revenue of $194.39MM vs $82.71MM (up 135.04%) and analysts estimated basic earnings per share -$2.02 vs -$4.17. Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.67. The estimated EPS forecast for the next fiscal year is -$1.27 and is expected to report on March 5th, 2019.

To read the full PTC Therapeutics, Inc. (PTCT) report, download it here: http://Fundamental-Markets.com/register/?so=PTCT

-----------------------------------------

AEROVIRONMENT, INC. (AVAV) REPORT OVERVIEW

AeroVironment's Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, AeroVironment reported revenue of $78.04MM vs $34.36MM (up 127.13%) and analysts estimated basic earnings per share $1.16 vs -$0.25. For the twelve months ended April 30th, 2018 vs April 30th, 2017, AeroVironment reported revenue of $271.05MM vs $228.94MM (up 18.39%) and analysts estimated basic earnings per share $0.86 vs $0.54 (up 59.26%). Analysts expect earnings to be released on December 4th, 2018. The report will be for the fiscal period ending October 31st, 2018. Reported EPS for the same quarter last year was $0.29. The estimated EPS forecast for the next fiscal year is $1.49 and is expected to report on June 25th, 2019.

To read the full AeroVironment, Inc. (AVAV) report, download it here: http://Fundamental-Markets.com/register/?so=AVAV

-----------------------------------------

AUTODESK, INC. (ADSK) REPORT OVERVIEW

Autodesk's Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, Autodesk reported revenue of $611.70MM vs $501.80MM (up 21.90%) and analysts estimated basic earnings per share -$0.18 vs -$0.66. For the twelve months ended January 31st, 2018 vs January 31st, 2017, Autodesk reported revenue of $2,056.60MM vs $2,031.00MM (up 1.26%) and analysts estimated basic earnings per share -$2.58 vs -$2.61. Analysts expect earnings to be released on November 27th, 2018. The report will be for the fiscal period ending October 31st, 2018. Reported EPS for the same quarter last year was -$0.42. The estimated EPS forecast for the next fiscal year is $2.22 and is expected to report on March 5th, 2019.

To read the full Autodesk, Inc. (ADSK) report, download it here: http://Fundamental-Markets.com/register/?so=ADSK

-----------------------------------------

COCA-COLA BOTTLING CO. CONSOLIDATED (COKE) REPORT OVERVIEW

Coca-Cola Bottling Co. Consolidated's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Coca-Cola Bottling Co. Consolidated reported revenue of $1,227.27MM vs $1,169.29MM (up 4.96%) and basic earnings per share -$0.42 vs $0.68. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Coca-Cola Bottling Co. Consolidated reported revenue of $4,323.67MM vs $3,156.43MM (up 36.98%) and analysts estimated basic earnings per share $10.35 vs $5.39 (up 92.09%). Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018.

To read the full Coca-Cola Bottling Co. Consolidated (COKE) report, download it here: http://Fundamental-Markets.com/register/?so=COKE

-----------------------------------------

AKERS BIOSCIENCES INC (AKER) REPORT OVERVIEW

Akers Biosciences' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Akers Biosciences reported revenue of $0.53MM vs $1.07MM (down 50.92%) and analysts estimated basic earnings per share -$0.02 vs -$0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Akers Biosciences reported revenue of $3.35MM vs $2.96MM (up 13.30%) and analysts estimated basic earnings per share -$0.78 vs -$0.61. Analysts expect earnings to be released on November 21st, 2018. The report will be for the fiscal period ending September 30th, 2018.

To read the full Akers Biosciences Inc (AKER) report, download it here: http://Fundamental-Markets.com/register/?so=AKER

-----------------------------------------

TEGNA INC. (TGNA) REPORT OVERVIEW

TEGNA's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, TEGNA reported revenue of $524.08MM vs $489.37MM (up 7.09%) and analysts estimated basic earnings per share $0.43 vs -$0.60. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TEGNA reported revenue of $1,903.03MM vs $2,004.09MM (down 5.04%) and analysts estimated basic earnings per share $1.27 vs $2.02 (down 37.13%). Analysts expect earnings to be released on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.23. The estimated EPS forecast for the next fiscal year is $1.42 and is expected to report on March 7th, 2019.

To read the full TEGNA Inc. (TGNA) report, download it here: http://Fundamental-Markets.com/register/?so=TGNA

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release